Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women
Stock Information for Evofem Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.